Good Quality Malaria Medicines Campaign - Health ...healthcommcapacity.org/wp-content/uploads/2016/11/Cheryl...Malaria Burden in Nigeria • Estimated 100 million malaria cases per

Good Quality Malaria Medicines Campaign

Akwa Ibom, Nigeria

Introduction •  Nigeria’s population of over 170 million makes it a

very attractive market for pharmaceuticals and other regulated products.

•  Over 60% of medicines are imported into Nigeria due to the gap created by inadequate in-country production of essential medicines.

•  This makes the country an easy target for poor quality medicines.

Malaria Burden in Nigeria

•  Estimated 100 million malaria cases per year

•  60% of out-patient visits and 30% of hospitalizations among children

•  With these types of statistics, the availability of poor quality antimalarial medicines is a major problem.

•  There has been a steady decline in the level of substandard and counterfeit antimalarial medicines in the country.

•  Various studies have shown: –  In 2008, 63.7% –  In 2011, 37% –  In 2012, 19.6% –  In 2015, 9.3%

Malaria Medicine Quality in Nigeria

4

•  NAFDAC and USP conducted a nationwide study of anti-malarials in 2015.

•  Results varied depending on zone—in the North east, poor quality medicines were more than 10 times higher than in the Southeast.

•  Both substandard and counterfeit anti-malarials were found, as were monotherapies.

Extent of the Problem

5

–  Instant scanning with Truscan for presence of active ingredients

–  Annual drug quality assessments using mini-labs –  Licensing of drug vendors, requiring minimum storage

standards –  NAFDAC phone line to report suspected counterfeit or

substandard drugs –  ACTs donated by Global Fund and PMI must be

purchased through pre-approved vendors. –  MAS scratch pads on all ACTs required by NAFDAC.

What is being done

Consumer Practices

•  Many people self-diagnose and self-prescribe,

•  Most purchase ACTs from unlicensed drugs,

•  Few consumers use the MAS scratchpad, •  Even where they encounter poor quality medicines, consumers rarely report to relevant authorities.

Campaign Strategy

Target audiences

Primary:Allconsumerswhobuyan3-malarials

Secondary:Drugvendors(PPMVs)purchase ACTs from unlicensed drugs,

Ter/ary:Policymakers,lawenforcement,Influen3almembersofsociety

What do we want them to do?

Consumers

•  Get diagnosed for malaria within 24 hrs. of fever onset •  Treat only with ACTs •  Purchase ACTs at licensed pharmacies or

PPMVs •  Check ACT pack for NAFDAC number & expiration date •  Use the scratch pad on ACT packets •  Report poor quality ACTs to NAFDAC.

PPMVs Feel pride in their business and consider themselves partners in efforts to eradicate malaria. Do: procure ACTs from registered pharmacies or wholesalers; handle and store medicines appropriately; allow patients to use scratch pad to verify authenticity before purchasing ACTs. Report suspicious activity or individuals to NAFDAC and MAD.

Policymakers, Influential Persons

Suffocate SSFFC medicines supply channels: –  Name, shame and punish culprits –  Tighten policies and legislation concerning

counterfeit and substandard malaria medicines –  Ban mono-therapies for malaria .

Materials

Poster

Booklet for Community Volunteers

Sticker for PPMV shops

Fact sheet for opinion leaders

Radio spots

TV Spot: https://www.youtube.com/

watch?v=6pxa8maSJ-E

Pilot-test in Akwa Ibom State, Nigeria

4-month campaign: •  Radio and TV spot broadcasts •  Stakeholders meeting •  Orientation for PPMVs •  Orientations for community volunteers •  Integration of SSFFC messages in malaria

outreach activities •  Journalist training & mentoring •  Posters and booklets

Evaluation

•  Baseline survey (2015) •  Follow-up omnibus survey (2016) •  Interviews with trained PPMVs •  Tracking community volunteer activities

Percent who had heard information about how to confirm quality of antimalarial medicine in the past 3 months

76.9 78.3 77.6

0

20

40

60

80

Male Female All

Percent of respondents who know at least two actions to confirm quality of malaria medicines, by communication exposure

40.9

57.3

82.7

0102030405060708090

Noexposure Exposedtoonesource Exposedtotwoormoresources

Percent of those exposed to campaign messages who intend to do something differently next time they need antimalarial medicine

72.02

24.97

3.01

0

10

20

30

40

50

60

70

80

Yes No Don’tknow

Percent

Actions respondents plan to take

0.6

18.2

29.5

33.5

36.1

0 5 10 15 20 25 30 35 40

Other

Getmalariamedicinesfromgovernmenthospitalsorbuyfromlicensedpharmacistsordrugshops

Checkformanufactureandexpirydateonthepacket

CheckforaNAFDACnumberonthepacket

Scratchthescratchpadonthepacketandtextthenumberunderneathtothenumberprovidedonthepacket

Percent